Brief: Carisma Therapeutics Says First In Vivo CAR-M Lead Candidate Nominated Under Carisma-Moderna Collaboration
14/12/2023 12:06
Dec 14 (Reuters) - Carisma Therapeutics Inc CARM.O :
* CARISMA THERAPEUTICS (NOT 'MODERNA INC')- FIRST LEAD
CANDIDATE
TO ADDRESS A SOLID TUMOR INDICATION WITH SIGNIFICANT UNMET
MEDICAL NEED
* CARISMA THERAPEUTICS - FIRST IN VIVO CAR-M LEAD CANDIDATE
NOMINATED UNDER CARISMA-MODERNA COLLABORATION
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Carisma Therapeutics
See all newsBrief: Carisma Therapeutics & Modernatx Amend Collaboration & And License Agreement - SEC Filing
Carisma Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Carisma Therapeutics Inc expected to post a loss of 9 cents a share - Earnings Preview
Brief: Carisma Therapeutics And Orthocellix Enter Into Definitive Merger Agreement
Carisma Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary